Simplex Trading
ADMA icon

Simplex Trading’s ADMA Biologics ADMA Stock Holding History

Simplex Trading’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$856K Buy
95,000
+16,600
+21% +$262K ﹤0.01% 2672
2025
Q4 		$1.43M Sell
78,400
-89,100
-53% -$1.5M ﹤0.01% 2262
2025
Q3 		$2.46M Buy
167,500
+107,200
+178% +$1.84M ﹤0.01% 2120
2025
Q2 		$1.1M Buy
60,300
+3,600
+6% +$73.4K ﹤0.01% 2691
2025
Q1 		$1.12M Buy
56,700
+26,900
+90% +$465K ﹤0.01% 2597
2024
Q4 		$511K Buy
29,800
+22,200
+292% +$418K ﹤0.01% 3508
2024
Q3 		$151K Sell
7,600
-900
-11% -$14K ﹤0.01% 4804
2024
Q2 		$95K Buy
8,500
+7,600
+844% +$63.8K ﹤0.01% 5424
2024
Q1 		$5K Buy
+900
New +$4.92K ﹤0.01% 7969
2023
Q4 		– Sell
-4,700
Closed -$16K – 8666
2023
Q3 		$16K Sell
4,700
-55,500
-92% -$214K ﹤0.01% 6794
2023
Q2 		$222K Sell
60,200
-6,800
-10% -$25.2K ﹤0.01% 4179
2023
Q1 		$221K Sell
67,000
-47,800
-42% -$165K ﹤0.01% 4202
2022
Q4 		$445K Sell
114,800
-3,700
-3% -$11.4K ﹤0.01% 3276
2022
Q3 		$287K Buy
118,500
+32,800
+38% +$78.7K ﹤0.01% 4134
2022
Q2 		$169K Buy
85,700
+68,000
+384% +$134K ﹤0.01% 4824
2022
Q1 		$32K Sell
17,700
-10,900
-38% -$17K ﹤0.01% 7686
2021
Q4 		$40K Sell
28,600
-227,000
-89% -$298K ﹤0.01% 7520
2021
Q3 		$406K Hold
255,600
– – ﹤0.01% 4417
2021
Q2 		$408K Buy
255,600
+253,136
+10,273% +$445K ﹤0.01% 4467
2021
Q1 		$433K Buy
2,464
+1,742
+241% +$3.99K ﹤0.01% 3575
2020
Q4 		$140K Buy
722
+576
+395% +$1.21K ﹤0.01% 5066
2020
Q3 		$34K Sell
146
-1,652
-92% -$4.53K ﹤0.01% 5953
2020
Q2 		$526K Buy
1,798
+38
+2% +$109 ﹤0.01% 2837
2020
Q1 		$506K Buy
+1,760
New +$6.08K ﹤0.01% 2568
2019
Q4 		– Sell
-70
Closed -$31K – 7196
2019
Q3 		$31K Buy
70
+1
+1% +$4 ﹤0.01% 5453
2019
Q2 		$26K Buy
+69
New +$305 ﹤0.01% 5382
2019
Q1 		– Sell
-9
Closed -$2K – 7043
2018
Q4 		$2K Buy
+9
New +$45 ﹤0.01% 6525

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Simplex Trading's ADMA Position: Q1 2026 in Review

Simplex Trading opened a new position in ADMA Biologics (ADMA) in Q1 2026: 54,917 shares worth $495K. The stake represents ﹤0.01% of the portfolio and ranks #3277 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ADMA as recently as Q3 2025.

Simplex Trading first reported a position in ADMA in Q3 2018 and has held it in 16 quarters since. The position peaked at $774K in Q3 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Simplex Trading held 54,917 shares of ADMA Biologics worth $495K as of Q1 2026.
  • ADMA Biologics was a new Simplex Trading position in Q1 2026.
  • ADMA Biologics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3277 holding.
  • Simplex Trading first reported a position in ADMA Biologics in Q3 2018 and has held it in 16 quarters since.
  • Simplex Trading's ADMA Biologics position peaked at $774K in Q3 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.